Page last updated: 2024-10-23

aspirin and Cardiomyopathy, Chagas

aspirin has been researched along with Cardiomyopathy, Chagas in 4 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"Based on the risk-benefit analysis, warfarin prophylaxis for cardioembolic stroke in Chagas' disease is recommended for patients with a score of 4-5 points, in whom the risk of CE overweighs the risk of a major bleeding."3.74Prevention strategies of cardioembolic ischemic stroke in Chagas' disease. ( Freitas, GR; Hasslocher-Moreno, A; Sousa, AS; Xavier, SS, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molina-Berríos, A1
Campos-Estrada, C1
Lapier, M1
Duaso, J1
Kemmerling, U1
Galanti, N1
Ferreira, J1
Morello, A1
López-Muñoz, R1
Maya, JD1
Ogata, H1
Teixeira, MM1
Sousa, RC1
Silva, MV1
Correia, D1
Rodrigues Junior, V1
Levy, BD1
Rogério, Ade P1
Sousa, AS1
Xavier, SS1
Freitas, GR1
Hasslocher-Moreno, A1
de Bracco, MM1
Sterin-Borda, L1
Fink, S1
Finiasz, M1
Borda, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical and Functional Effects of Cardiac Contractility Modulation in Chagas Heart Disease: a Randomized Study - Contractility - FIX-Chagas[NCT05519046]60 participants (Anticipated)Interventional2022-05-06Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for aspirin and Cardiomyopathy, Chagas

ArticleYear
Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.
    Parasitology research, 2013, Volume: 112, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Aspirin; Chagas Cardiomyopathy; Chronic Disease; Disease Models,

2013
Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease.
    European journal of pharmacology, 2016, Apr-15, Volume: 777

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cell Proliferation;

2016
Prevention strategies of cardioembolic ischemic stroke in Chagas' disease.
    Arquivos brasileiros de cardiologia, 2008, Volume: 91, Issue:5

    Topics: Anticoagulants; Aspirin; Brain Ischemia; Chagas Cardiomyopathy; Epidemiologic Methods; Female; Hemor

2008
Stimulatory effect of lymphocytes from Chagas' patients on spontaneously beating rat atria.
    Clinical and experimental immunology, 1984, Volume: 55, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Catechols; Chagas Cardiomyopathy; Chagas Disease;

1984